Company intelligence / Profile preview

Aspargo Laboratories

New York City, New York, United Statesaspargolabs.com ↗
Ownership
Private
Development stage
NDA
01

Overview

Aspargo Labs has developed a proprietary oral suspension formulation of sildenafil citrate (ASP‑001), achieving regulatory approval and commercial launch under the brand names HEZKUE® in Germany and BANDOL® in Spain. The product has also received approval in the UK, Mexico, Ireland, and the Netherlands. Clinical trials have been completed to support an NDA submission to the FDA. Top-line results from bioavailability studies show comparable absorption to Viagra®, with ongoing expansion into new geographies and additional products under development.

Therapeutic areas
OtherMen's Health
Modalities
Oral suspensions (liquid formulations)Oral spraysSmall molecules (notably sildenafil citrate)
Industry
Biotech
02

Drug pipeline

4 assets

ASP-001

4

3 more assets in the full pipeline.

Request access →
03

Partnerships

Exclusive license/supply agreement with Laboratorio SIDUS for Argentina market expansion.No major pharma partnerships disclosed.

Beyond the preview

Go deeper on Aspargo Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aspargo Laboratories.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call